Boothbay Fund Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.27M | Buy |
19,213
+9,123
| +90% | +$2.97M | 0.12% | 162 |
|
|
2025
Q1 | $2.72M | Buy |
+10,090
| New | +$2.72M | 0.07% | 276 |
|
|
2024
Q4 | – | Sell |
-2,556
| Closed | -$703K | – | 1298 |
|
|
2024
Q3 | $703K | Sell |
2,556
-830
| -25% | -$228K | 0.02% | 716 |
|
|
2024
Q2 | $823K | Sell |
3,386
-11,630
| -77% | -$2.83M | 0.02% | 677 |
|
|
2024
Q1 | $2.24M | Buy |
+15,016
| New | +$2.24M | 0.04% | 392 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 1460 |
|
|
2022
Q4 | – | Sell |
-1,093
| Closed | -$219K | – | 1717 |
|
|
2022
Q3 | $219K | Sell |
1,093
-6,791
| -86% | -$1.36M | 0.01% | 1498 |
|
|
2022
Q2 | $1.15M | Buy |
+7,884
| New | +$1.15M | 0.03% | 668 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 1869 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 1660 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 1633 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 1654 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 1278 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1055 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 899 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 822 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 736 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 734 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 660 |
|
|
2019
Q2 | – | Sell |
-12,800
| Closed | -$1.2M | – | 622 |
|
|
2019
Q1 | $1.2M | Buy |
+12,800
| New | +$1.2M | 0.12% | 145 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 566 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 652 |
|
|
2018
Q2 | – | Sell |
-2,666
| Closed | -$318K | – | 607 |
|
|
2018
Q1 | $318K | Sell |
2,666
-666
| -20% | -$79.4K | 0.04% | 352 |
|
|
2017
Q4 | $423K | Buy |
+3,332
| New | +$423K | 0.06% | 262 |
|
|
2017
Q3 | – | Sell |
-4,186
| Closed | -$334K | – | 513 |
|
|
2017
Q2 | $334K | Buy |
+4,186
| New | +$334K | 0.07% | 300 |
|